Ignite Creation Date:
2024-05-06 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03151382
Status:
UNKNOWN
Last Update Posted:
2017-05-12
First Post:
2017-05-08
Brief Title:
A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease
Sponsor:
Zhejiang Provincial Peoples Hospital
Organization:
Zhejiang Provincial Peoples Hospital
Study Overview
Official Title:
A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease
Status:
UNKNOWN
Status Verified Date:
2017-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective Evaluation the improvement of the cognitive function of tandospirone add-on treatment on patients with AD comorbid anxiety
Number of Patients 30
Methodology Randomized open-label parallel-group
Assigned Interventions Experimental Tandospirone 30-60 mgd Donepezil 10 mgd Control group Donepezil 10 mgd
Effect Evaluation Primary Outcome Change from baseline in ADAS-cog total score at week 12 NPI scale total score at week 12
Number of Patients 30
Methodology Randomized open-label parallel-group
Assigned Interventions Experimental Tandospirone 30-60 mgd Donepezil 10 mgd Control group Donepezil 10 mgd
Effect Evaluation Primary Outcome Change from baseline in ADAS-cog total score at week 12 NPI scale total score at week 12
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SED-AD-2016-001 | OTHER | Sumitomo Pharma Suzhou CoLtd | None |